The Dermatology Digest

NOVEMBER 4, 2024

“The MDR CE Mark certification for Estyme , is a critical milestone in our strategic path to expand our product portfolio and reflects our commitment to delivering high-quality gels that adhere to the most rigorous regulatory standards,” says David Moatazedi, President and Chief Executive Officer of Evolus, in a news release.

Injections 68

Injections Medical Portfolios Branding 68

The Dermatology Digest

AUGUST 12, 2024

The purchase price represents a premium of 89% over Revance’s closing market price on August 9, 2024, and a 111% premium to Revance’s 60-day volume-weighted average price. per share in cash, representing a total enterprise value of $924 million. ” Mark J. ” The transaction is expected to close by year end.

Portfolios 69

Portfolios Innovations Marketing Office 69

The Dermatology Digest

MARCH 27, 2024

Alexis (Lexi) Stern is Merz Aesthetics’ new Chief Marketing Officer. Stern will join the global leadership team and will be responsible for leading the portfolio and brand strategies. Stern served as Senior Vice President of Global Marketing at Covergirl, Coty Inc.’s Most recently, Ms.

Office 36

Office Portfolios Branding Marketing 36

The Dermatology Digest

MARCH 26, 2024

Formally described as the Approved Drug Products with Therapeutic Equivalence Evaluations, the Orange Book is an FDA publication that provides a list of drugs approved as safe and effective and also serves as the regulatory resource for information on drug marketing availability, bioequivalence, drug substitution, and patent and exclusivity data.

Pharmaceutical 36

Pharmaceutical Portfolios Office Marketing 36

The Dermatology Digest

APRIL 1, 2024

“We are excited to announce the addition of this collaboration for povorcitinib, expanding our relationship with CMS in the Dermatology space beyond ruxolitinib cream, to include two products with the potential to help patients with limited treatment options,” says Hervé Hoppenot, Chief Executive Officer, Incyte, in a news release.

Portfolios 36

Portfolios Injections Innovations Sales 36

The Dermatology Digest

OCTOBER 1, 2024

“We are encouraged by the outcome from the recent FDA meeting and the opportunity to advance our development of prabotulinumtoxinA utilizing the 351(k) biosimilar regulatory pathway,” says Marc Forth, AEON’s President and Chief Executive Officer, in a news release. “We

Portfolios 36

Portfolios Hydration Office Surgery 36

Southeastern Esthetics Institute

AUGUST 23, 2016

Specific courses for cosmetic lasers, for example, are crucial to add to the esthetics portfolio, in order to showcase added training beyond that of the esthetics fundamentals course. A complete system must be in place per office, for the role of every action within the practice.

Esthetician 195

Esthetician Esthetics Document Office 195